Dear Reader,

We are pleased to introduce the third and final issue of Volume I of *Journal of Law and the Biosciences* (JLB). During this inaugural year, the journal has published a number of original articles on such issues as biomedical ethics, genetic research policy, cognitive enhancement devices, biobanks, research participation consent, reproductive technologies, genomic technology in the military, and open access of publicly funded research. With each issue, we have also introduced new submission types, including new developments written by law and graduate students and letters originally submitted to the Presidential Commission for the Study of Bioethical Issues.

In this issue, we are delighted to include two other submission types. First, peer commentaries provide experts in a specific field an opportunity to share their views on an article within that field that has been published in the journal. Commentators can provide critiques, different perspectives, and complementary materials. In this issue, we include five commentaries on 'The Regulation of Cognitive Enhancement Devices,' by Julian Savulescu et al., published in our first issue. These commentaries further explore European regulation of cognitive enhancement, well-being, and harm reduction.

Further, in this issue we have included our first book review, a review of Lawrence O. Gostin\'s *Pursuing Global Health with Justice: A Review of Global Health Law*. For future issues, we will continue to publish reviews of scholarship related to advances at the intersection of law and the biosciences.

We hope you have enjoyed reading our first volume, and we look forward to an exciting second year.

Sincerely,

> **I. Glenn Cohen,** JD
>
> *Co-Editor-in-Chief*, Journal of Law and the Biosciences, *Harvard Law School*
>
> **Nita Farahany,** JD, PhD
>
> *Co-Editor-in-Chief*, Journal of Law and the Biosciences, *Duke University*
>
> **Hank Greely,** JD
>
> *Co-Editor-in-Chief*, Journal of Law and the Biosciences, *Stanford University*
